Skip to main content

ETHNOS_APP

Home • Search • Journals • List 0

Vani Vannappagari

Biographic Data

ID7728596
NAMEVani Vannappagari
GIVEN NAMESVani
FAMILY NAMEVannappagari
SIGNATUREVANNAPPAGARI V
AFFILIATIONSViiV Healthcare
ORCID0000-0002-0157-9689
VERIFIEDYes
TOTAL WORKS4
TOTAL CITATIONS0
WORKS AS AUTHOR4
WORKS AS EDITOR0
FIRST PUBLICATION YEAR2024
LATEST PUBLICATION YEAR2026
H-INDEX0
  • The Role of Healthcare-Related Experiences in Willingness and Preference for Long-Acting Injectable PrEP (LAI-PrEP) Among Transfeminine People in the United States

    Open Access•Jennifer L Glick, Danielle F Nestadt et al.•ARTICLE•AIDS and Behavior•2026

    Transgender women and transfeminine people (TWTFP) experience disproportionately high HIV prevalence, low HIV pre-exposure prophylaxis (PrEP) coverage, and negative healthcare experiences. Long-acting injectable PrEP (LAI-PrEP) and daily oral-PrEP are delivered under different healthcare interaction protocols. We examined the role of healthcare-related experiences on willingness and preference for LAI-PrEP among a U.S. nationwide sample of sexual…

  • Correlation between sexual behavior and preferences for HIV pre-exposure prophylaxis modality among men who have sex with men

    Jeb Jones, Duygu Islek et al.•ARTICLE•AIDS Care•2025

    Demographic, behavioral, and clinical characteristics have been found to be associated with willingness to use and preferences for different HIV pre-exposure prophylaxis (PrEP) modalities. Limited data are available, however, describing how sexual behavior characteristics affect willingness to use and preferences for PrEP. Given the different clinical characteristics of available PrEP modalities (i.e., daily oral, on-demand oral, long-acting inje…

  • Promising results of HIV prevention trials highlight the benefits of collaboration in global health

    Open Access•Robin Schaefer, L J Donaldson et al.•ARTICLE•PLOS Global Public Health•2024

    This work was supported, in whole or in part, by the Bill & Melinda Gates Foundation [INV045445]. Under the grant conditions of the Foundation, a Creative Commons Attribution 4.0 Generic License has already been assigned to the Author Accepted Manuscript version that might arise from this submission. The Forum for Collaborative Research, as an organization, also receives grants from the pharmaceutical industry but these are unrestricted and not s…

  • Preference for Long-Acting HIV Prevention Methods Among Transgender Women Vulnerable to HIV in Eastern and Southern United States

    Open Access•Erin Cooney, Megan Stevenson et al.•ARTICLE•AIDS and Behavior•2024

No prominent works on this page.

  • Promising results of HIV prevention trials highlight the benefits of collaboration in global health

    Open Access•Robin Schaefer, L J Donaldson et al.•ARTICLE•PLOS Global Public Health•2024

    This work was supported, in whole or in part, by the Bill & Melinda Gates Foundation [INV045445]. Under the grant conditions of the Foundation, a Creative Commons Attribution 4.0 Generic License has already been assigned to the Author Accepted Manuscript version that might arise from this submission. The Forum for Collaborative Research, as an organization, also receives grants from the pharmaceutical industry but these are unrestricted and not s…

  • Preference for Long-Acting HIV Prevention Methods Among Transgender Women Vulnerable to HIV in Eastern and Southern United States

    Open Access•Erin Cooney, Megan Stevenson et al.•ARTICLE•AIDS and Behavior•2024

  • Correlation between sexual behavior and preferences for HIV pre-exposure prophylaxis modality among men who have sex with men

    Jeb Jones, Duygu Islek et al.•ARTICLE•AIDS Care•2025

    Demographic, behavioral, and clinical characteristics have been found to be associated with willingness to use and preferences for different HIV pre-exposure prophylaxis (PrEP) modalities. Limited data are available, however, describing how sexual behavior characteristics affect willingness to use and preferences for PrEP. Given the different clinical characteristics of available PrEP modalities (i.e., daily oral, on-demand oral, long-acting inje…

  • The Role of Healthcare-Related Experiences in Willingness and Preference for Long-Acting Injectable PrEP (LAI-PrEP) Among Transfeminine People in the United States

    Open Access•Jennifer L Glick, Danielle F Nestadt et al.•ARTICLE•AIDS and Behavior•2026

    Transgender women and transfeminine people (TWTFP) experience disproportionately high HIV prevalence, low HIV pre-exposure prophylaxis (PrEP) coverage, and negative healthcare experiences. Long-acting injectable PrEP (LAI-PrEP) and daily oral-PrEP are delivered under different healthcare interaction protocols. We examined the role of healthcare-related experiences on willingness and preference for LAI-PrEP among a U.S. nationwide sample of sexual…

HIV/AIDS Research and Interventions (4 works) · Pre-exposure prophylaxis (3 works) · Family medicine (2 works) · HIV, Drug Use, Sexual Risk (2 works) · LGBTQ Health, Identity, and Policy (2 works) · Medicine (2 works) · Men who have sex with men (2 works) · Preference (2 works) · Psychology (2 works) · Public health (2 works)

Ethnos_APP • Open Source Project • MIT License • Frontend v2.0.0 • Privacy and Cookies • API Documentation: api.ethnos.app/docs • API Source Code: GitHub • DOI: 10.5281/zenodo.17049435 • Frontend Source Code: GitHub • DOI: 10.5281/zenodo.17050053 • cruz.rio.br • Expectantes Misericordiae